偉易達(00303.HK)料疫情下截至3月止全年度收入將按年持平(更正)
偉易達(00303.HK)公布,在新型冠狀病毒疫情下,由於大量國內工人延遲返回工作崗位,導致集團回復正常運作的進度較平常慢。即使集團已加快生產活動,仍預期於今年首季在內地的產能將會損失約三分之一,而每年首季是集團業務的付運淡季,故此集團預期截至3月底止全年度收入,將與2019財政年度相若,較集團於2019年11月公布中期業績時的預期為低。公司補充,預期旗下內地工廠將於今年4月回復正常產能,但將取決於新型冠狀病毒的疫情發展,以及供應鏈的恢復進度。(sw/w)(更正:2020/03/06 08:27 偉易達(00303.HK)料疫情下截至3月止全年度收入將按年持平)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.